Entos Finds $53M For Drug Design Platform
socalTECH
JULY 16, 2021
San Diego-based Entos, a developer of artificial intelligence and automated synthetic development technology for designing small-molecule therapeutics, has raised $53M in a Series A funding. The funding was led by Coatue, and also included Catalio Capital Management, OrbiMed, Sequoia CApital, Nexus Ventures, and Freeflow.
Let's personalize your content